(Q45259898)

11 December 2017

Systemic lupus erythematosus in childhood correlations between changes in disease activity and serum complement levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A956959

systemic lupus erythematosus

10 August 2022

main subject

1 reference

B. H. Singsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A956959

10 August 2022

B. H. Bernstein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A956959

10 August 2022

K. K. King

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A956959

10 August 2022

V. Hanson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A956959

10 August 2022

language of work or name

English

0 references

publication date

1 September 1976

1 reference

The Journal of Pediatrics

11 December 2017

1 reference

11 December 2017

89

1 reference

11 December 2017

358-369

1 reference

11 December 2017

3

1 reference

Immunological studies in nephritis

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

The localization of in vivo bound complement in tissue section

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

Immunologic factors and clinical activity in systemic lupus erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

Antinulear factors in childhood rheumatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

DNA antibodies in childhood scleroderma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

Immunologic events preceding clinical exacerbation of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

Clinical studies of hemolytic complement and the 11S component

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

Complement in disseminated (systemic) lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

An immunofluorescent study of the skin lesions in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

THE APPLICATION OF THE FLUORESCENT ANTIBODY TECHNIC TO THE INVESTIGATION OF LUPUS ERYTHEMATOSUS AND VARIOUS DERMATOSES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

Immunoglobulin deposits in skin in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

"BOUND" COMPLEMENT IN THE SKIN OF PATIENTS WITH CHRONIC DISCOID LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

Experimental skin lesions in mice resembling systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

The neurological manifestations of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

The Fourth Component of Complement in the Cerebrospinal Fluid in Systemic Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

Neurological and psychiatric signs associated with systemic lupus erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

THE PROGNOSIS IN "ORGANIC BRAIN" SYNDROMES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

The complement system of man. 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980528-8

10.1016/S0022-3476(76)80528-8

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference